A Pilot Study to Evaluate the Pharmacokinetics of Omega-3 Between Rosuvastatin and Omega-3 Coadministration and HCP1007

A Pilot Study to Evaluate the Pharmacokinetics of Omega-3 Between Rosuvastatin and Omega-3 Coadministration and HCP1007 in Healthy Male Volunteers

The purpose of this study is to evaluate the pharmacokinetics of omega-3 between rosuvastatin and omega-3 coadministration and HCP1007 in healthy male volunteers.

Inclusion Criteria:

• Adult male aged 20 to 55 years
• A body mass index between 19 and 27 kg/m2

Exclusion Criteria:

• History of hepatobiliary, renal, gastrointestinal, respiratory, musculoskeletal, endocrinal, hemato-oncologic or cardiovascular disease
• SBP < 90 or ≥ 150 mmHg, DBP < 60 or ≥90 mmHg
• Use of herbal medicine within 30 days, prescriptive medicine within 14 days, or over-the-counter drug within 7 days
• Heavy alcohol consumption (140 g/day)